Cargando…
DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer’s disease
Measures of change in hippocampal volume derived from longitudinal MRI are a well-studied biomarker of disease progression in Alzheimer’s disease (AD) and are used in clinical trials to track therapeutic efficacy of disease-modifying treatments. However, longitudinal MRI change measures based on def...
Autores principales: | Dong, Mengjin, Xie, Long, Das, Sandhitsu R., Wang, Jiancong, Wisse, Laura E.M., deFlores, Robin, Wolk, David A., Yushkevich, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604562/ https://www.ncbi.nlm.nih.gov/pubmed/34450261 http://dx.doi.org/10.1016/j.neuroimage.2021.118514 |
Ejemplares similares
-
Regional Deep Atrophy: a Self-Supervised Learning Method to Automatically Identify Regions Associated With Alzheimer’s Disease Progression From Longitudinal MRI
por: Dong, Mengjin, et al.
Publicado: (2023) -
Longitudinal atrophy in early Braak regions in preclinical Alzheimer's disease
por: Xie, Long, et al.
Publicado: (2020) -
Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
por: Xie, Long, et al.
Publicado: (2023) -
Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
por: McCollum, Lauren E., et al.
Publicado: (2021) -
Aging and Alzheimer’s disease have dissociable effects on local and regional medial temporal lobe connectivity
por: Hrybouski, Stanislau, et al.
Publicado: (2023)